Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia
Pu Xia(Integrated Chinese Medicine (China)), George L. King(Joslin Diabetes Center), Peter J. Oates(Pfizer (United States)), Toyoshi Inoguchi(Kyushu University), Ronald L. Engerman(University of Wisconsin–Madison), Timothy S. Kern(University of California, Irvine)
Cited by 456
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979